NEW UPDATE ALERT.....................

Lamotrigine is an antiepileptic medication used to treat epilepsy and mood disorders such as bipolar disorder. The U.S. Food and Drug Administration (FDA) issued a new warning regarding the risk for hemophagocytic lymphohistiocytosis (HLH), which is a rare immune system reaction.

Go to the profile of Michael Weitz
Apr 29, 2018
2
0

McGraw-Hill INTERNAL UPDATES FORM

Date:

April 29, 2018

Site:

accesspharmacy.com

Title of Book and Edition:

Pharmacotherapy: A Pathophysiologic Approach, 10th Edition

Author:

DiPiro JT, et al, eds.

Chapter number/chapter title:

Chapter 56: Epilepsy

Location of Update in the chapter:

Treatment, Pharmacologic Therapy

 

Content Update

April 29, 2018

Risk of Hemophagocytic Lymphohistiocytosis with Lamotrigine Use: Lamotrigine is an antiepileptic medication used for management of epilepsy and mood disorders such as bipolar disorder. The U.S. Food and Drug Administration issued a new warning regarding the risk for hemophagocytic lymphohistiocytosis (HLH), which is a rare immune system reaction.

Go to the profile of Michael Weitz

Michael Weitz

Editor, McGraw Hill

No comments yet.